Kidney Biopsy Market Report Evaluates Growth Drivers, Challenges And Market Dynamics

The kidney biopsy market is on the path to steady expansion as medical technologies and diagnostic needs evolve. With growing awareness around kidney health and advancements in biopsy techniques, this sector is set to experience notable growth through the coming decade. Let's explore the market size, key players, emerging trends, and important segments shaping the future of kidney biopsy procedures.

Projected Market Size and Growth Outlook for the Kidney Biopsy Market
Forecasts suggest that the kidney biopsy market will increase to $2.86 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.7%. This upward trend is driven by several factors including the rising prevalence of diabetes-related kidney conditions, wider adoption of ultrasound- and CT-guided biopsy methods, heightened demand for early detection of kidney diseases, and improvements in imaging technology. Additionally, expanding access to specialized nephrology care is contributing to this growth. Key patterns expected to influence the market include a shift towards minimally invasive biopsy techniques, greater use of image-guided percutaneous biopsies, escalating demand for precise renal disease diagnostics, the expanding role of biopsies in transplant monitoring, and ongoing enhancements in the safety and accuracy of renal tissue sampling.

The kidney biopsy market size has grown strongly in recent years. It will grow from $2.26 billion in 2025 to $2.38 billion in 2026 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to rising prevalence of chronic kidney disease, increasing incidence of glomerulonephritis and nephrotic syndrome, established clinical reliance on renal biopsy for diagnosis, growth in kidney transplant procedures, expansion of tertiary care hospitals.

Download a free sample of the kidney biopsy market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Top Companies Leading the Kidney Biopsy Industry
The kidney biopsy market is dominated by a range of influential companies such as Cardinal Health, Medtronic plc, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Becton dic*kinson and Company, Boston Scientific Corporation, Olympus Corporation, Hitachi Ltd., Canon Medical Systems Corporation, Cook Medical, B. Braun Melsungen AG, Merit Medical Systems Inc., Argon Medical Devices Inc., Stryker Corporation, Integra LifeSciences Corporation, Leica Biosystems, Hologic Inc., Samsung Medison Co. Ltd., Mindray Medical International Limited, Terumo Corporation, and Fujifilm Holdings Corporation. These firms drive innovation and provide a broad range of biopsy-related technologies and services worldwide.

Advances in AI Integration in Kidney Biopsy Diagnostics
In March 2025, the Netherlands-based pathology software firm Aiosyn teamed up with Pramana, a US digital pathology technology company, to introduce real-time AI processing for kidney biopsy analysis. Their collaboration aims to combine Aiosyn's NephroPath AI algorithms with Pramana's digital pathology platform to speed up biopsy workflows, improve diagnostic precision through automated tissue quantification, and boost efficiency with edge-based, on-device AI processing. Pramana specializes in automated whole-slide imaging systems embedded with advanced AI capabilities at the edge, enabling faster and more accurate pathology assessments.

View the full kidney biopsy market report:
https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Artificial Intelligence Trends Enhancing the Kidney Biopsy Market
Leading companies in the kidney biopsy field are increasingly embedding artificial intelligence (AI) into their platforms to improve diagnostic accuracy, streamline workflows, and enhance patient care. AI technologies assist by refining image analysis, offering diagnostic support, aiding treatment planning, providing predictive insights, and facilitating kidney disease research. For example, in March 2024, Aiosyn launched the NephroPath platform, which uses computational pathology algorithms to analyze kidney biopsy histological biomarkers. This includes identifying different tissue types, measuring interstitial fibrosis, and precisely quantifying and assessing glomeruli. The AI-driven system ensures consistent, detailed, and reproducible scoring of renal pathology markers, addressing limitations of conventional scoring methods and reducing observer variability.

Core Segmentation Structure of the Global Kidney Biopsy Market
This report categorizes the kidney biopsy market into several key segments:
1) By Type of Biopsy: Percutaneous Biopsy and Surgical Biopsy
2) By Clinical Indication: Kidney Failure, Kidney Transplant, Hematuria, and Proteinuria
3) By End-User: Hospitals and Clinics, Tertiary Care Centers, and Other Healthcare Facilities

Further sub-segmentation includes:
- Percutaneous Biopsy types such as Ultrasound-Guided Biopsy and CT-Guided Biopsy
- Surgical Biopsy types including Open Kidney Biopsy and Laparoscopic Kidney Biopsy

These classifications provide a comprehensive framework for understanding market dynamics and focusing on specific areas of growth and demand within the kidney biopsy domain.

New analytical features added to our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.